Concepedia

Bin Zhao

BZ

30

Publications

2.6K

Citations

19

H-Index

1992

Active since

Affiliations

Second Affiliated Hospital & Yuying Children's Hospital of Wenzhou Medical University(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Wenzhou Medical University

Third Affiliated Hospital of Harbin Medical University

Harbin Medical University

Bin Zhao is an author at Second Affiliated Hospital & Yuying Children's Hospital of Wenzhou Medical University specializing in medicine, radiation oncology, and oncology.

ORCID

Top concepts

Publications per year

1992–2024

30

Publications

30

Five-Year Outcomes With Pembrolizumab Versus Chemotherapy for Metastatic Non–Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score ≥ 50%

Martin Reck, Delvys Rodríguez‐Abreu, Andrew Robinson et al. · Journal of Clinical Oncology · 2021 · 1K citations · Full text

Macropinocytosis Is the Endocytic Pathway That Mediates Macrophage Foam Cell Formation with Native Low Density Lipoprotein

Howard S. Kruth, Nancy Lee Jones, Wei Huang et al. · Journal of Biological Chemistry · 2004 · 272 citations · Full text

Efficacy of PD-1/PD-L1 blockade monotherapy in clinical trials

Bin Zhao, Hong Zhao, Jiaxin Zhao · Therapeutic Advances in Medical Oncology · 2020 · 212 citations · Full text

Outcomes With Pembrolizumab Plus Platinum-Based Chemotherapy for Patients With NSCLC and Stable Brain Metastases: Pooled Analysis of KEYNOTE-021, -189, and -407

Steven Powell, Delvys Rodríguez‐Abreu, Corey J. Langer et al. · Journal of Thoracic Oncology · 2021 · 176 citations · Full text

Long-Term Overall Survival From KEYNOTE-021 Cohort G: Pemetrexed and Carboplatin With or Without Pembrolizumab as First-Line Therapy for Advanced Nonsquamous NSCLC

Mark M. Awad, Shirish M. Gadgeel, Hossein Borghaei et al. · Journal of Thoracic Oncology · 2020 · 175 citations

, , +7

Rows per page

1–5 of 30